UnitedHealth Group Inc. (UNH) Scheduled to Post Earnings on Tuesday
UnitedHealth Group Inc. (NYSE:UNH) is set to release its Q316 earnings data on Tuesday, October 18th. Analysts expect UnitedHealth Group to post earnings of $2.08 per share and revenue of $46.11 billion for the quarter.
UnitedHealth Group Inc. (NYSE:UNH) opened at 133.92 on Monday. The firm has a 50 day moving average of $137.02 and a 200-day moving average of $136.52. The stock has a market cap of $127.54 billion, a PE ratio of 20.96 and a beta of 0.57. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a yield of 1.87%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s payout ratio is currently 39.12%.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/unitedhealth-group-inc-unh-scheduled-to-post-earnings-on-tuesday.html
In related news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now directly owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.65% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of UNH. AXA boosted its stake in shares of UnitedHealth Group by 4.9% in the second quarter. AXA now owns 1,053,508 shares of the healthcare conglomerate’s stock worth $148,755,000 after buying an additional 49,280 shares during the last quarter. GAM Holding AG boosted its stake in UnitedHealth Group by 24.2% in the second quarter. GAM Holding AG now owns 285,177 shares of the healthcare conglomerate’s stock valued at $40,267,000 after buying an additional 55,524 shares in the last quarter. Atlantic Trust Group LLC boosted its stake in UnitedHealth Group by 1.7% in the second quarter. Atlantic Trust Group LLC now owns 1,063,265 shares of the healthcare conglomerate’s stock valued at $150,133,000 after buying an additional 17,444 shares in the last quarter. Van Hulzen Asset Management LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $104,000. Finally, Engineers Gate Manager LP boosted its stake in UnitedHealth Group by 634.5% in the second quarter. Engineers Gate Manager LP now owns 21,300 shares of the healthcare conglomerate’s stock valued at $3,008,000 after buying an additional 18,400 shares in the last quarter. 85.78% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages recently weighed in on UNH. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $161.00 target price (up from $145.00) on shares of UnitedHealth Group in a research note on Friday, July 22nd. Barclays PLC upped their target price on shares of UnitedHealth Group from $151.00 to $164.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 20th. Citigroup Inc. upped their target price on shares of UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a research note on Wednesday, July 20th. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a report on Friday, July 22nd. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price target for the company in a report on Friday, July 22nd. One analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $155.35.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.